CRISPR Therapeutics AG - Common Shares (CRSP) SEC filings
CRSP SEC filings moved a median of -0.16% by the close. CRSP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CRSP overview →
58 measured CRSP SEC filing events.
Where these CRSP SEC filings landedvs 58 measured CRSP SEC filing reactions
| Middle 50% of CRSP SEC filing reactions | -2.11% to +2.57% |
|---|---|
| Median reaction (to close) | -0.16% |
| Measured reactions | 58 |
Point-in-time · zero look-ahead
Half of the 58 CRSP SEC filing events with a measured close landed between -2.11% and +2.57%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CRISPR Therapeutics AG For: Jun 30 | SEC filing · Form 10-Q | +2.58% | +5.09% | |
| Form 8-K CRISPR Therapeutics AG For: Aug 03 | SEC filing · Form 8-K | +2.58% | +5.09% | |
| Form S-8 CRISPR Therapeutics AG | SEC filing · Form S-8 | -1.39% | -6.90% | |
| Form 8-K CRISPR Therapeutics AG For: Jun 04 | SEC filing · Form 8-K | -1.39% | -6.90% | |
| Form 10-Q CRISPR Therapeutics AG For: Mar 31 | SEC filing · Form 10-Q | +1.29% | -0.23% | |
| Form 8-K CRISPR Therapeutics AG For: May 04 | SEC filing · Form 8-K | +1.29% | -0.23% | |
| Form ARS CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form ARS | -0.80% | -3.34% | |
| Form DEF 14A CRISPR Therapeutics AG For: Jun 04 | SEC filing · Form DEF | -0.80% | -3.34% | |
| Form DEFA14A CRISPR Therapeutics AG | SEC filing · Form DEFA14A | -0.80% | -3.34% | |
| Form PRE 14A CRISPR Therapeutics AG For: Jun 04 | SEC filing · Form PRE | +0.92% | -1.11% | |
| Form 8-K CRISPR Therapeutics AG For: Mar 16 | SEC filing · Form 8-K | +0.41% | +2.43% | |
| Form 8-K CRISPR Therapeutics AG For: Mar 10 | SEC filing · Form 8-K | -0.64% | -4.00% | |
| Form 10-K CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form 10-K | +4.76% | +6.70% | |
| Form 8-K CRISPR Therapeutics AG For: Feb 12 | SEC filing · Form 8-K | +4.76% | +6.70% | |
| Form 8-K CRISPR Therapeutics AG For: Jan 12 | SEC filing · Form 8-K | -0.65% | +2.41% | |
| Form 10-Q CRISPR Therapeutics AG For: Sep 30 | SEC filing · Form 10-Q | -1.01% | -6.22% | |
| Form 8-K CRISPR Therapeutics AG For: Nov 10 | SEC filing · Form 8-K | -1.01% | -6.22% | |
| Form 8-K CRISPR Therapeutics AG For: Oct 15 | SEC filing · Form 8-K | +0.59% | -2.24% | |
| Form 10-Q CRISPR Therapeutics AG For: Jun 30 | SEC filing · Form 10-Q | -2.49% | +2.94% | |
| Form 8-K CRISPR Therapeutics AG For: Aug 04 | SEC filing · Form 8-K | -2.49% | +2.94% | |
| Form 8-K CRISPR Therapeutics AG For: Jun 26 | SEC filing · Form 8-K | -2.27% | -0.79% | |
| Form 8-K CRISPR Therapeutics AG For: Jun 05 | SEC filing · Form 8-K | +0.82% | +0.16% | |
| Form 8-K CRISPR Therapeutics AG For: May 19 | SEC filing · Form 8-K | -1.66% | +1.26% | |
| Form 10-Q CRISPR Therapeutics AG For: Mar 31 | SEC filing · Form 10-Q | -2.27% | -0.75% | |
| Form 8-K CRISPR Therapeutics AG For: May 06 | SEC filing · Form 8-K | -2.27% | -0.75% | |
| Form ARS CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form ARS | +1.10% | +1.37% | |
| Form DEF 14A CRISPR Therapeutics AG For: Jun 05 | SEC filing · Form DEF | +1.10% | +1.37% | |
| Form DEFA14A CRISPR Therapeutics AG | SEC filing · Form DEFA14A | +1.10% | +1.37% | |
| Form PRE 14A CRISPR Therapeutics AG For: Jun 05 | SEC filing · Form PRE | +1.06% | +2.03% | |
| Form 8-K CRISPR Therapeutics AG For: Mar 24 | SEC filing · Form 8-K | +0.44% | -2.46% | |
| Form 10-K CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form 10-K | +0.55% | +6.47% | |
| Form 8-K CRISPR Therapeutics AG For: Feb 11 | SEC filing · Form 8-K | +0.55% | +6.47% | |
| Form 10-Q CRISPR Therapeutics AG For: Sep 30 | SEC filing · Form 10-Q | -1.34% | +2.57% | |
| Form 8-K CRISPR Therapeutics AG For: Nov 05 | SEC filing · Form 8-K | -1.34% | +2.57% | |
| Form 10-Q CRISPR Therapeutics AG For: Jun 30 | SEC filing · Form 10-Q | -4.03% | -1.75% | |
| Form 8-K CRISPR Therapeutics AG For: Aug 05 | SEC filing · Form 8-K | -4.03% | -1.75% | |
| Form S-3ASR CRISPR Therapeutics AG | SEC filing · Form S-3ASR | -4.03% | -1.75% | |
| Form S-8 CRISPR Therapeutics AG | SEC filing · Form S-8 | -4.03% | -1.75% | |
| Form 8-K CRISPR Therapeutics AG For: May 30 | SEC filing · Form 8-K | +1.59% | +4.25% | |
| Form 8-K CRISPR Therapeutics AG For: May 23 | SEC filing · Form 8-K | -2.54% | -1.88% | |
| Form 10-Q CRISPR Therapeutics AG For: Mar 31 | SEC filing · Form 10-Q | +2.64% | +2.98% | |
| Form 8-K CRISPR Therapeutics AG For: May 08 | SEC filing · Form 8-K | +2.64% | +2.98% | |
| Form ARS CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form ARS | -0.17% | -0.58% | |
| Form DEF 14A CRISPR Therapeutics AG For: May 30 | SEC filing · Form DEF | -0.17% | -0.58% | |
| Form DEFA14A CRISPR Therapeutics AG | SEC filing · Form DEFA14A | -0.17% | -0.58% | |
| Form PRE 14A CRISPR Therapeutics AG For: May 30 | SEC filing · Form PRE | -1.46% | -2.60% | |
| Form 10-K CRISPR Therapeutics AG For: Dec 31 | SEC filing · Form 10-K | -2.78% | -0.10% | |
| Form 8-K CRISPR Therapeutics AG For: Feb 21 | SEC filing · Form 8-K | -2.78% | -0.10% | |
| Form 8-K CRISPR Therapeutics AG For: Feb 13 | SEC filing · Form 8-K | +2.07% | +0.54% | |
| Form 8-K CRISPR Therapeutics AG For: Jan 16 | SEC filing · Form 8-K | -1.19% | -2.23% | |
| Form 8-K CRISPR Therapeutics AG For: Dec 14 | SEC filing · Form 8-K | -0.70% | -7.86% | |
| Form 8-K CRISPR Therapeutics AG For: Dec 15 | SEC filing · Form 8-K | +0.06% | -2.19% | |
| Form 8-K CRISPR Therapeutics AG For: Dec 12 | SEC filing · Form 8-K | +0.94% | +7.30% | |
| Form 8-K CRISPR Therapeutics AG For: Dec 08 | SEC filing · Form 8-K | +0.06% | -3.19% | |
| Form 8-K CRISPR Therapeutics AG For: Dec 04 | SEC filing · Form 8-K | -1.42% | -0.07% | |
| Form 8-K CRISPR Therapeutics AG For: Nov 15 | SEC filing · Form 8-K | -0.79% | +2.00% | |
| Form 10-Q CRISPR Therapeutics AG For: Sep 30 | SEC filing · Form 10-Q | +0.15% | +11.71% | |
| Form 8-K CRISPR Therapeutics AG For: Nov 06 | SEC filing · Form 8-K | +0.15% | +11.71% |
Keep exploring
More CRSP: earnings → · analyst actions → · CRSP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Merus N.V. - Common Shares (MRUS) | 292 | +0.03% | 54% |
| Trinity Biotech plc - American Depositary Shares (TRIB) | 292 | -0.13% | 44% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.